Search by Drug Name or NDC

    NDC 00517-4002-25 Papaverine Hydrochloride 30 mg/mL Details

    Papaverine Hydrochloride 30 mg/mL

    Papaverine Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Regent, Inc.. The primary component is PAPAVERINE HYDROCHLORIDE.

    Product Information

    NDC 00517-4002
    Product ID 0517-4002_0a4f7219-b60d-46ff-9c63-e21271569771
    Associated GPIs 40100060102005
    GCN Sequence Number 000527
    GCN Sequence Number Description papaverine HCl VIAL 30 MG/ML INJECTION
    HIC3 A7C
    HIC3 Description VASODILATORS,PERIPHERAL
    GCN 02100
    HICL Sequence Number 000170
    HICL Sequence Number Description PAPAVERINE HCL
    Brand/Generic Generic
    Proprietary Name Papaverine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Papaverine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 30
    Active Ingredient Units mg/mL
    Substance Name PAPAVERINE HYDROCHLORIDE
    Labeler Name American Regent, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 00517-4002-25 (00517400225)

    NDC Package Code 0517-4002-25
    Billing NDC 00517400225
    Package 25 VIAL in 1 CARTON (0517-4002-25) / 2 mL in 1 VIAL (0517-4002-01)
    Marketing Start Date 1995-09-01
    NDC Exclude Flag N
    Pricing Information N/A